UnknownPhase 2/3

Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases

Egypt50 participantsStarted 2022-04-14

Plain-language summary

Suprachoroidal injection is a safe way for intraocular drug delivery. It was used to treat various retinal conditions.

Who can participate

Age range20 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients diagnosed as central serous chorioretinopathy and patients with cystoid macular edema due to irvine-gass syndrome after cataract surgery. Exclusion Criteria: * other retinal diseases that may affect CMT and final visual outcome. * Patients with dense corneal opacity.

What they're measuring

Central macular thickness

Timeframe: Baseline and 12 months after injection.

Trial details

NCT IDNCT05337332

SponsorBenha University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-05-30

Contact for this trial

Ahmed Abdelshafy, MD

01222328766 ahmad4lg@gmail.com

View on ClinicalTrials.gov More Central Serous Chorioretinopathy trials